It is believed that there are a lot of study and work to be done in China for standardizing the interventional therapy, in spite of PTRA/S already been the first choice of RAS therapy in the world.

• 虽然国内外已将(PTRA/S)作为RAS的首选治疗，但国内相关临床研究有待加强。